Online first
Case report
Published online: 2024-09-04

open access

Page views 260
Article views/downloads 108
Get Citation

Connect on Social Media

Connect on Social Media

An unusual coexistence of Mondor’s disease and hidradenitis suppurativa

Zuzanna Świerczewska1, Patrycja Rogowska1, Wioletta Barańska-Rybak1

Abstract

Hidradenitis suppurativa (HS), also known as acne inversa, is a chronic, debilitating inflammatory skin disease defined by the occurrence of painful inflamed nodules, abscesses, sinus tracts, and fistulas. Patients frequently present with several comorbidities nonetheless, the topic is still often neglected. Here, this study reports the first case of Mondor’s disease (MD) in a patient with recently diagnosed hidradenitis suppurativa. A 52-year-old Caucasian man presented with nodules, scarring and fistulas primarily affecting the anogenital area and right thigh, diagnosed 3 months earlier as HS. Moreover, the physical examination revealed multiple lipomas in the trunk area and a palpable subcutaneous 10 cm cord-like structure along the anterolateral wall of the thorax on the right side that appeared 2 weeks before the admission. The patient did not have a history of trauma, infection, malignancy, previous thromboembolic events, excessive training, or any procedure. Laboratory tests performed revealed increased CRP, D-dimer, and haematocrit levels. A thrombosed hypoechoic superficial vein with no Doppler flow was observed during the ultrasound examination of the affected area. Regarding the anamnesis and the clinical picture, a diagnosis of Mondor’s disease was made. Mondor’s disease is a rare condition that resolves spontaneously in four to eight weeks however, it is often underdiagnosed owing to a lack of awareness.

Article available in PDF format

View PDF Download PDF file

References

  1. Sabat R, Jemec GBE, Matusiak Ł, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020; 6(1): 18.
  2. Miller IM, McAndrew RJ, Hamzavi I. Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin. 2016; 34(1): 7–16.
  3. Mondor H. Tronculite sous-cutané subaigue de la paroi thoracique antero-laterale. Mem Acad Chir. 1939; 65: 1271–1278.
  4. Goldman A, Wollina U. Mondor's disease after aesthetic breast surgery: a case series and literature review. J Cutan Aesthet Surg. 2018; 11(3): 132–135.
  5. Ramos-Rodríguez D, Garcias-Ladaria J, Serra Soler G, et al. Hidradenitis suppurativa in a transgender man. Clin Exp Dermatol. 2021; 46(7): 1305–1306.
  6. Buonomo M, Mansh MD, Thorpe D, et al. Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy. Br J Dermatol. 2021; 184(6): 1192–1194.
  7. Kamal K, Afzal N, Ziad A, et al. Association between exogenous testosterone use and new diagnosis of hidradenitis suppurativa: a case series. JAAD Case Rep. 2024; 44: 27–29.
  8. Walker RF, Zakai NA, MacLehose RF, et al. Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism. JAMA Intern Med. 2020; 180(2): 190–197.